![Steven Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Smith
Operationeel Directeur bij AshHill Investments LLC
Profiel
Steven R Smith is currently the Chief Operating Officer at AshHill Investments LLC and a Partner at Cincinnati.
He was previously a Board Member at Heart Metabolics Ltd.
Smith received an undergraduate degree from the University of Cincinnati and a graduate degree from the University of Dayton School of Law.
Actieve functies van Steven Smith
Bedrijven | Functie | Begin |
---|---|---|
AshHill Investments LLC
![]() AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Operationeel Directeur | - |
Cincinnati | Private Equity Investor | - |
Eerdere bekende functies van Steven Smith
Bedrijven | Functie | Einde |
---|---|---|
Heart Metabolics Ltd.
![]() Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Directeur/Bestuurslid | - |
Opleiding van Steven Smith
University of Cincinnati (Ohio) | Undergraduate Degree |
University of Dayton School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
AshHill Investments LLC
![]() AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Finance |
Cincinnati | Finance |
Heart Metabolics Ltd.
![]() Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |